CTIX will be presenting at ASM Microbe 2016 on Jun
Post# of 72440
Pharmacokinetic-pharmacodynamic(Pk?Pd) Analyses for Efficacy and Safety of Brilacidin (Bri) Using Data fromPatients with Acute Bacterial Skin and Skin Structure Infections (Absssi)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18058
Application of Pharmacokinetic-Pharmacodynamic (Pk‑Pd) Models for Brilacidin (Bri) Dose Selection Support for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18096